COMMUNIQUÉS West-GlobeNewswire

NANOBIOTIX Strengthens Financial Position Through Amendment of Global Licensing Agreement for JNJ-1900 (NBTXR3) and Extends Cash Visibility to Mid-2026

17/03/2025 - 21:15

Conference call and webcast scheduled for March 18, 2025, at 8:30 A.M. EDT / 1:30 P.M. CET PARIS and CAMBRIDGE, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘ Company ’’), [...]

NANOBIOTIX renforce sa visibilité financière en amendant son accord de licence globale pour JNJ-1900 (NBTXR3) qui étend son horizon de trésorerie jusqu’à mi-2026

17/03/2025 - 21:15

Conférence téléphonique et diffusion en direct prévues le 18 mars 2025 à 8h30 EST / 13h30 CET PARIS et CAMBRIDGE, Mass., 17 mars 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société »), [...]

Gyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

17/03/2025 - 21:15

Data from pivotal Phase 3 trial in CHB-associated liver fibrosis expected in Q2 2025 Commercial launch in the PRC of generic nintedanib for the treatment of IPF and avatrombopag maleate tablets for the treatment of CLD- [...]

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

17/03/2025 - 21:05

BRISBANE, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical [...]

Metagenomi Reports Business Updates and Full Year 2024 Financial Results

17/03/2025 - 21:05

Hemophilia A presentation at American Society of Hematology (ASH) 66th Annual Meeting demonstrated sustained Factor VIII (FVIII) activity in nonhuman primate (NHP) study for more than 16 months Leveraged hemophilia A [...]

Nanox to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025

17/03/2025 - 21:05

PETACH TIKVA, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial [...]

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

17/03/2025 - 21:05

GUILFORD, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic [...]

OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation

17/03/2025 - 21:05

WARSAW, Ind., March 17, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today [...]

AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific

17/03/2025 - 21:05

VALENCIA, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced it has entered into [...]

FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results

17/03/2025 - 21:05

Announced sale of FibroGen China to AstraZeneca for a total consideration of approximately $160 million Transaction expected to close by mid-2025 Upon close of sale of FibroGen China, cash runway extended into 2027 [...]

Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

17/03/2025 - 21:05

Announced positive preliminary 12-week clinical results, building on already released 4-week results, of ongoing type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without [...]

Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

17/03/2025 - 21:01

Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT SOUTH SAN FRANCISCO, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical [...]

BridgeBio Announces CFO Succession

17/03/2025 - 21:01

PALO ALTO, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced that Thomas [...]

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results

17/03/2025 - 21:00

MARLBOROUGH, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced its financial results for the fourth quarter and full year ending [...]

SAFE - Signature d’un avenant n°4 au contrat de financement obligataire en vigueur afin de poursuivre le retournement stratégique de Safe

17/03/2025 - 20:56

Avertissement : La société SAFE SA (la « Société ») a mis en place un financement sous forme d’obligations convertibles en actions nouvelles ou existantes (OCEANE) avec Global Corporate Finance Opportunities 20 (« GCFO [...]

Better Choice Company Board of Directors Approves Up to 55% Annual Royalty Distribution Plan from its Halo Brand

17/03/2025 - 18:28

TAMPA, Fla., March 17, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced that its Board of Directors have [...]

Investigational Rinatabart Sesutecan (Rina-S®) Continues to Show Encouraging Antitumor Activity in Patients with Advanced Ovarian Cancer

17/03/2025 - 17:19

Media Release COPENHAGEN, Denmark; March 17, 2025 Results from Phase 2 RAINFOL TM -01 trial (B1 cohort) showed that with a median on-study follow-up of 48 weeks, Rina-S 120 mg/m 2 led to a confirmed objective response [...]

Recover Red Debuts Innovative PEMF+ Grounding Mat, Transforming At-Home Therapy

17/03/2025 - 17:13

PITTSBURGH, March 17, 2025 (GLOBE NEWSWIRE) -- Recover Red , a leader in advanced wellness technology, has launched the PEMF+ Grounding Mat, a next-generation therapy device designed to revolutionize holistic health. By [...]

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

17/03/2025 - 16:15

ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 17 MARCH 2025 at 17.15 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]